Drug Profile
Research programme: nanoparticle-based cancer vaccines - Therapeutics Solutions International
Alternative Names: Exosomes - Therapeutics Solutions InternationalLatest Information Update: 28 Dec 2019
Price :
$50
*
At a glance
- Originator Institute for Molecular Medicine; John Wayne Cancer Institute; Therapeutics Solutions International
- Class Antineoplastics
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 28 Dec 2019 No recent reports of development identified for research development in Cancer in USA
- 23 Nov 2015 Therapeutics Solutions International has patents pending for nanoparticle-based cancer vaccines in US
- 23 Nov 2015 Early research in Cancer in USA (unspecified route)